FIELD: molecular biotechnology; medicine.
SUBSTANCE: invention concerns a genetic construct carrying guide RNA genes complementary to the flanking regions of exon 7 of the human SMN1 gene. The presence of U6 promoters ensures expression in human cells, and the presence of a constitutive part (scaffold) ensures recognition of guide RNAs synthesized in the cell by nucleases of the CRISPR system that recognize NGG PAM.
EFFECT: invention makes it possible to create cell lines that model human spinal muscular atrophy, which can be used to study therapeutic agents for this disease.
1 cl, 1 dwg
Authors
Dates
2024-04-08—Published
2022-06-22—Filed